Literature DB >> 31108411

A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals.

Mie Balling1, Anne Langsted1, Shoaib Afzal1, Anette Varbo1, George Davey Smith2, Børge G Nordestgaard3.   

Abstract

BACKGROUND AND AIMS: Increased concentrations of calculated remnant cholesterol in triglyceride-rich lipoproteins are observationally and genetically, causally associated with increased risk of ischemic heart disease; however, when measured directly, the fraction of plasma cholesterol present in remnant particles is unclear. We tested the hypothesis that a major fraction of plasma cholesterol is present in remnant lipoproteins in individuals in the general population.
METHODS: We examined 9293 individuals from the Copenhagen General Population Study using nuclear magnetic resonance spectroscopy measurements of total cholesterol, free- and esterified cholesterol, triglycerides, phospholipids, and particle concentration. Fourteen subclasses of decreasing size and their lipid constituents were analysed: six subclasses were very low-density lipoprotein (VLDL), one intermediate-density lipoprotein (IDL), three low-density lipoprotein (LDL), and four subclasses were high-density lipoprotein (HDL). Remnant lipoproteins were VLDL and IDL combined.
RESULTS: Mean nonfasting cholesterol concentration was 1.84 mmol/L (72 mg/dL) for remnants, 2.01 mmol/L (78 mg/dL) for LDL, and 1.83 mmol/L (71 mg/dL) for HDL, equivalent to remnants containing 32% of plasma total cholesterol. Of 14 lipoprotein subclasses, large LDL and IDL were the ones containing most of plasma cholesterol. The plasma concentration of remnant cholesterol was from ∼1.4 mmol/L (54 mg/dL) at age 20 to ∼1.9 mmol/L (74 mg/dL) at age 60. Corresponding values for LDL cholesterol were from ∼1.5 mmol/L (58 mg/dL) to ∼2.1 mmol/L (81 mg/dL).
CONCLUSIONS: Using direct measurements, one third of total cholesterol in plasma was present in remnant lipoproteins, that is, in the triglyceride-rich lipoproteins IDL and VLDL.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular disease; Cholesterol; Lipoproteins; Nuclear magnetic resonance

Mesh:

Substances:

Year:  2019        PMID: 31108411     DOI: 10.1016/j.atherosclerosis.2019.05.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

Review 1.  Apolipoprotein E and Atherosclerosis.

Authors:  A D Marais
Journal:  Curr Atheroscler Rep       Date:  2021-05-10       Impact factor: 5.113

Review 2.  Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation.

Authors:  Ron C Hoogeveen; Christie M Ballantyne
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

Review 3.  Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease.

Authors:  Alan Chait; Henry N Ginsberg; Tomas Vaisar; Jay W Heinecke; Ira J Goldberg; Karin E Bornfeldt
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

4.  Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.

Authors:  Stephanie T Chung; Celeste K L Cravalho; Abby G Meyers; Amber B Courville; Shanna Yang; Nirupa Rachel Matthan; Lilian Mabundo; Maureen Sampson; Ronald Ouwerkerk; Ahmed M Gharib; Alice H Lichtenstein; Alan T Remaley; Anne E Sumner
Journal:  Circ Res       Date:  2019-10-18       Impact factor: 17.367

5.  Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance.

Authors:  Jin Chen; Jie Kuang; Xiaoyu Tang; Ling Mao; Xin Guo; Qin Luo; Daoquan Peng; Bilian Yu
Journal:  Lipids Health Dis       Date:  2020-06-10       Impact factor: 3.876

6.  Associations Between Bioavailable Vitamin D and Remnant Cholesterol in Patients With Type 2 Diabetes Mellitus.

Authors:  Gulsum Feyza Turkes; Sezer Uysal; Tevfik Demir; Yucel Demiral; Baris Onder Pamuk; Husnu Yılmaz; Leyla Demir; Mehmet Doruk; Giray Bozkaya
Journal:  Cureus       Date:  2021-02-09

7.  Triglyceride-containing lipoprotein sub-fractions and risk of coronary heart disease and stroke: A prospective analysis in 11,560 adults.

Authors:  Roshni Joshi; S Goya Wannamethee; Jorgen Engmann; Tom Gaunt; Deborah A Lawlor; Jackie Price; Olia Papacosta; Tina Shah; Therese Tillin; Nishi Chaturvedi; Mika Kivimaki; Diana Kuh; Meena Kumari; Alun D Hughes; Juan P Casas; Steve Humphries; Aroon D Hingorani; A Floriaan Schmidt
Journal:  Eur J Prev Cardiol       Date:  2020-01-29       Impact factor: 7.804

8.  Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.

Authors:  Renato Quispe; Seth Shay Martin; Erin Donelly Michos; Isha Lamba; Roger Scott Blumenthal; Anum Saeed; Joao Lima; Rishi Puri; Sarah Nomura; Michael Tsai; John Wilkins; Christie Mitchell Ballantyne; Stephen Nicholls; Steven Richard Jones; Mohamed Badreldin Elshazly
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

9.  Establishing reference intervals for triglyceride-containing lipoprotein subfraction metabolites measured using nuclear magnetic resonance spectroscopy in a UK population.

Authors:  Roshni Joshi; Goya Wannamethee; Jorgen Engmann; Tom Gaunt; Deborah A Lawlor; Jackie Price; Olia Papacosta; Tina Shah; Therese Tillin; Peter Whincup; Nishi Chaturvedi; Mika Kivimaki; Diana Kuh; Meena Kumari; Alun D Hughes; Juan P Casas; Steve E Humphries; Aroon D Hingorani; A Floriaan Schmidt
Journal:  Ann Clin Biochem       Date:  2020-10-21       Impact factor: 2.057

10.  Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.

Authors:  Henry N Ginsberg; Chris J Packard; M John Chapman; Jan Borén; Carlos A Aguilar-Salinas; Maurizio Averna; Brian A Ference; Daniel Gaudet; Robert A Hegele; Sander Kersten; Gary F Lewis; Alice H Lichtenstein; Philippe Moulin; Børge G Nordestgaard; Alan T Remaley; Bart Staels; Erik S G Stroes; Marja-Riitta Taskinen; Lale S Tokgözoğlu; Anne Tybjaerg-Hansen; Jane K Stock; Alberico L Catapano
Journal:  Eur Heart J       Date:  2021-12-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.